Avantor (NYSE:AVTR) Given Neutral Rating at UBS Group

Avantor (NYSE:AVTR - Get Free Report)'s stock had its "neutral" rating reissued by UBS Group in a research note issued to investors on Friday, MarketBeat.com reports. They presently have a $25.00 price target on the stock, down from their previous price target of $29.00. UBS Group's price target suggests a potential upside of 12.91% from the stock's previous close.

A number of other equities research analysts have also weighed in on AVTR. Robert W. Baird dropped their target price on Avantor from $27.00 to $26.00 and set an "outperform" rating for the company in a report on Monday, October 28th. Wells Fargo & Company cut their target price on shares of Avantor from $30.00 to $28.00 and set an "overweight" rating on the stock in a report on Monday, October 28th. Royal Bank of Canada reissued an "outperform" rating and set a $34.00 price target on shares of Avantor in a research report on Thursday, September 26th. Finally, Barclays decreased their price objective on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a research report on Friday, October 25th. Three equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $27.38.

Avantor Trading Down 1.9 %

Shares of AVTR stock traded down $0.43 on Friday, hitting $22.14. 6,042,606 shares of the company's stock traded hands, compared to its average volume of 4,492,800. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54. The stock has a market capitalization of $15.07 billion, a price-to-earnings ratio of 48.13, a P/E/G ratio of 3.42 and a beta of 1.28. The company's fifty day simple moving average is $21.46 and its 200 day simple moving average is $23.34. Avantor has a one year low of $19.59 and a one year high of $28.00.

Hedge Funds Weigh In On Avantor

Institutional investors and hedge funds have recently made changes to their positions in the business. State Street Corp raised its position in Avantor by 58.0% in the third quarter. State Street Corp now owns 22,368,244 shares of the company's stock worth $578,666,000 after acquiring an additional 8,206,695 shares during the period. 1832 Asset Management L.P. raised its holdings in Avantor by 1,634.9% in the 2nd quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company's stock worth $180,839,000 after purchasing an additional 8,038,451 shares during the period. The Manufacturers Life Insurance Company lifted its position in Avantor by 653.0% during the third quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company's stock valued at $159,740,000 after purchasing an additional 5,354,678 shares in the last quarter. FMR LLC grew its holdings in Avantor by 557.2% during the third quarter. FMR LLC now owns 4,675,283 shares of the company's stock valued at $120,950,000 after purchasing an additional 3,963,912 shares during the period. Finally, Sound Shore Management Inc. CT bought a new stake in Avantor during the second quarter valued at about $76,412,000. Hedge funds and other institutional investors own 95.08% of the company's stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.